Visual Abstract

Background: Noncompaction cardiomyopathy (NC) is a rare congenital heart disease characterized by progressive heart failure and life-threatening arrhythmias. Heart rate turbulence (HRT) has been defined as a noninvasive prognostic method to reveal the cardiac death risk in high-risk patients. Objectives: We aimed to assess the cardiac autonomic functions and their relations to the mortality in NC patients. Methods: A total of 60 NC patients and 70 healthy controls were included in this study. All participants underwent 24-h Holter recording to assess the HRT parameters, included turbulence onset (TO), turbulence slope (TS), standard deviation of NN intervals of all normal beats (SDNN) and mean RR interval. Results: NC patients had higher levels of TO than the control group (0.43 ± 4.66% vs. –1.82 ± 2.19%, p = 0.024), but the TS levels of NC patients were lower than those of the control group (3.43 ± 3.28 vs. 4.94 ± 2.86 ms/RR, p = 0.024). Thirteen patients died during follow-up (mean 83.3 ± 32.5 months). TS was the strongest univariate mortality predictor (hazard ratio 10.01 [95% CI 2.22–42.52]; p = 0.004) in univariate Cox regression analysis. In multivariate analysis, LVEF ≤0.40 and TS ≤2.5 ms/RR interval were the only independent predictors of mortality (hazard ratio 5.29; p = 0.004, hazard ratio 13.45; p = 0.001, respectively). Conclusions: Patients with NC showed abnormal HRV and HRT parameters when compared to healthy subjects. Furthermore, impaired HRT reaction in NC is an independent predictor of mortality.

1.
Jenni
R
,
Oechslin
E
,
Schneider
J
,
Attenhofer Jost
C
,
Kaufmann
PA
.
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy
.
Heart
.
2001
Dec
;
86
(
6
):
666
71
.
[PubMed]
1355-6037
2.
Caliskan
K
,
Ujvari
B
,
Bauernfeind
T
,
Theuns
DA
,
Van Domburg
RT
,
Akca
F
, et al.
The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias
.
J Cardiovasc Electrophysiol
.
2012
Sep
;
23
(
9
):
938
44
.
[PubMed]
1045-3873
3.
Towbin
JA
.
Left ventricular noncompaction cardiomyopathy. Cardioskeletal Myopathies in Children and Young Adults
.
Elsevier
;
2017
. pp.
153
71
.
4.
Rigopoulos
A
,
Rizos
IK
,
Aggeli
C
,
Kloufetos
P
,
Papacharalampous
X
,
Stefanadis
C
, et al.
Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults
.
Cardiology
.
2002
;
98
(
1-2
):
25
32
.
[PubMed]
0008-6312
5.
Guzik
P
,
Schmidt
G
.
A phenomenon of heart-rate turbulence, its evaluation, and prognostic value
.
Card Electrophysiol Rev
.
2002
Sep
;
6
(
3
):
256
61
.
[PubMed]
1385-2264
6.
Golukhova
EZ
,
Gromova
O
,
Grigoryan
M
,
Merzlyakov
V
,
Shumkov
K
,
Bockeria
L
, et al.
Noninvasive predictors of malignant arrhythmias
.
Cardiology
.
2016
;
135
(
1
):
36
42
.
[PubMed]
0008-6312
7.
Schmidt
G
,
Malik
M
,
Barthel
P
,
Schneider
R
,
Ulm
K
,
Rolnitzky
L
, et al.
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction
.
Lancet
.
1999
Apr
;
353
(
9162
):
1390
6
.
[PubMed]
0140-6736
8.
Camm
A
,
Malik
M
,
Bigger
J
,
Breithardt
G
,
Cerutti
S
,
Cohen
R
, et al.;
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
.
Heart rate variability: standards of measurement, physiological interpretation and clinical use
.
Circulation
.
1996
Mar
;
93
(
5
):
1043
65
.
[PubMed]
0009-7322
9.
Wellens
HJ
,
Schwartz
PJ
,
Lindemans
FW
,
Buxton
AE
,
Goldberger
JJ
,
Hohnloser
SH
, et al.
Risk stratification for sudden cardiac death: current status and challenges for the future
.
Eur Heart J
.
2014
Jul
;
35
(
25
):
1642
51
.
[PubMed]
0195-668X
10.
Jacquier
A
,
Thuny
F
,
Jop
B
,
Giorgi
R
,
Cohen
F
,
Gaubert
JY
, et al.
Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction
.
Eur Heart J
.
2010
May
;
31
(
9
):
1098
104
.
[PubMed]
0195-668X
11.
Bauer
A
,
Malik
M
,
Schmidt
G
,
Barthel
P
,
Bonnemeier
H
,
Cygankiewicz
I
, et al.
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus
.
J Am Coll Cardiol
.
2008
Oct
;
52
(
17
):
1353
65
.
[PubMed]
0735-1097
12.
Group
MP
;
Multicenter Postinfarction Research Group
.
Risk stratification and survival after myocardial infarction
.
N Engl J Med
.
1983
Aug
;
309
(
6
):
331
6
.
[PubMed]
0028-4793
13.
La Rovere
MT
,
Bigger
JT
 Jr
,
Marcus
FI
,
Mortara
A
,
Schwartz
PJ
,
Investigators
A
;
ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators
.
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
.
Lancet
.
1998
Feb
;
351
(
9101
):
478
84
.
[PubMed]
0140-6736
14.
Schwartz
PJ
,
La Rovere
MT
,
Vanoli
E
.
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification
.
Circulation
.
1992
Jan
;
85
(
1
Suppl
):
I77
91
.
[PubMed]
0009-7322
15.
Vanoli
E
,
De Ferrari
GM
,
Stramba-Badiale
M
,
Hull
SS
 Jr
,
Foreman
RD
,
Schwartz
PJ
.
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction
.
Circ Res
.
1991
May
;
68
(
5
):
1471
81
.
[PubMed]
0009-7330
16.
Sade
E
,
Oto
A
, editors
.
Post-Extrasystolic Heart Rate Turbulence as a Risk Predictor.
Cardiac Arrhythmias 2001:
Proceedings of the 7th International Workshop on Cardiac Arrhythmias
(
Venice
,
7–10 October 2001
);
2013
:
Springer.
17.
Mirea
O
,
Berceanu
M
,
Constantin
A
,
Mănescu
M
,
Târtea
GC
,
Donoiu
I
, et al.
Non-compaction cardiomyopathy–brief review
.
Journal of Mind and Medical Sciences.
2017
;
4
(
2
):
115
24
.
18.
Ghuran
A
,
Reid
F
,
La Rovere
MT
,
Schmidt
G
,
Bigger
JT
 Jr
,
Camm
AJ
, et al.;
ATRAMI Investigators
.
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy)
.
Am J Cardiol
.
2002
Jan
;
89
(
2
):
184
90
.
[PubMed]
0002-9149
19.
Camm
AJ
,
Julian
D
,
Janse
G
,
Munoz
A
,
Schwartz
P
,
Simon
P
, et al.;
EMIAT Investigators
.
The European myocardial infarct amiodarone trial (EMIAT)
.
Am J Cardiol
.
1993
Nov
;
72
(
16
):
95F
8F
.
[PubMed]
0002-9149
20.
Jeron
A
,
Kaiser
T
,
Hengstenberg
C
,
Löwel
H
,
Riegger
GA
,
Holmer
S
.
Association of the heart rate turbulence with classic risk stratification parameters in postmyocardial infarction patients
.
Ann Noninvasive Electrocardiol
.
2003
Oct
;
8
(
4
):
296
301
.
[PubMed]
1082-720X
21.
Mäkikallio
TH
,
Barthel
P
,
Schneider
R
,
Bauer
A
,
Tapanainen
JM
,
Tulppo
MP
, et al.
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era
.
Eur Heart J
.
2005
Apr
;
26
(
8
):
762
9
.
[PubMed]
0195-668X
22.
Barthel
P
,
Schneider
R
,
Bauer
A
,
Ulm
K
,
Schmitt
C
,
Schömig
A
, et al.
Risk stratification after acute myocardial infarction by heart rate turbulence
.
Circulation
.
2003
Sep
;
108
(
10
):
1221
6
.
[PubMed]
0009-7322
23.
Nucifora
G
,
Aquaro
GD
,
Masci
PG
,
Pingitore
A
,
Lombardi
M
.
Magnetic resonance assessment of prevalence and correlates of right ventricular abnormalities in isolated left ventricular noncompaction
.
Am J Cardiol
.
2014
Jan
;
113
(
1
):
142
6
.
[PubMed]
0002-9149
24.
Zhang
Y
,
Post
WS
,
Blasco-Colmenares
E
,
Dalal
D
,
Tomaselli
GF
,
Guallar
E
.
Electrocardiographic QT interval and mortality: a meta-analysis
.
Epidemiology
.
2011
Sep
;
22
(
5
):
660
70
.
[PubMed]
1044-3983
25.
Onrat
E
,
Kaya
D
,
Çelik
A
,
Melek
M
,
Kerpeten
K
,
Kilit
C
, et al.
Heart Rate Turbulence Does Not Seem To Be A Good Predıctor in Long Qt Syndrome
.
Archives of The Turkish Society of Cardiology.
2003
;
31
(
12
):
770
5
.
26.
Papaioannou
VE
.
Heart rate variability, baroreflex function and heart rate turbulence: possible origin and implications
.
Hellenic J Cardiol
.
2007
Sep-Oct
;
48
(
5
):
278
89
.
[PubMed]
1109-9666
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.